Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Cash from Investing Activities: 2019-2025

Historic Cash from Investing Activities for Benitec Biopharma (BNTC) over the last 7 years, with Jun 2025 value amounting to -$18,000.

  • Benitec Biopharma's Cash from Investing Activities rose 96.65% to -$6,000 in Q1 2025 from the same period last year, while for Mar 2025 it was -$210,000, marking a year-over-year decrease of 218.18%. This contributed to the annual value of -$18,000 for FY2025, which is 89.94% up from last year.
  • Benitec Biopharma's Cash from Investing Activities amounted to -$18,000 in FY2025, which was up 89.94% from -$179,000 recorded in FY2024.
  • In the past 5 years, Benitec Biopharma's Cash from Investing Activities ranged from a high of -$1,000 in FY2023 and a low of -$221,000 during FY2021.
  • Its 3-year average for Cash from Investing Activities is -$66,000, with a median of -$18,000 in 2025.
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first spiked by 94.12% in 2022, then slumped by 17,800.00% in 2024.
  • Yearly analysis of 5 years shows Benitec Biopharma's Cash from Investing Activities stood at -$221,000 in 2021, then surged by 94.12% to -$13,000 in 2022, then skyrocketed by 92.31% to -$1,000 in 2023, then tumbled by 17,800.00% to -$179,000 in 2024, then spiked by 89.94% to -$18,000 in 2025.